FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

784927000: Product containing precisely dextromethorphan hydrobromide 30 milligram and guaifenesin 600 milligram/1 each prolonged-release oral tablet (clinical drug)


Status: current, Defined. Date: 31-Jul 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3765774012 Product containing precisely dextromethorphan hydrobromide 30 milligram and guaifenesin 600 milligram/1 each prolonged-release oral tablet (clinical drug) en Fully specified name Active Case insensitive SNOMED CT core
3765775013 Dextromethorphan hydrobromide 30 mg and guaifenesin 600 mg prolonged-release oral tablet en Synonym Active Case insensitive SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dextromethorphan hydrobromide 30 mg and guaifenesin 600 mg prolonged-release oral tablet Has presentation strength numerator unit mg true Inferred relationship Some 1
Dextromethorphan hydrobromide 30 mg and guaifenesin 600 mg prolonged-release oral tablet Has presentation strength denominator unit Tablet true Inferred relationship Some 2
Dextromethorphan hydrobromide 30 mg and guaifenesin 600 mg prolonged-release oral tablet Has BoSS Dextromethorphan hydrobromide true Inferred relationship Some 1
Dextromethorphan hydrobromide 30 mg and guaifenesin 600 mg prolonged-release oral tablet Has presentation strength denominator unit Tablet true Inferred relationship Some 1
Dextromethorphan hydrobromide 30 mg and guaifenesin 600 mg prolonged-release oral tablet Has presentation strength denominator value 1 false Inferred relationship Some 1
Dextromethorphan hydrobromide 30 mg and guaifenesin 600 mg prolonged-release oral tablet Has presentation strength numerator value 600 false Inferred relationship Some 2
Dextromethorphan hydrobromide 30 mg and guaifenesin 600 mg prolonged-release oral tablet Has presentation strength denominator value 1 false Inferred relationship Some 2
Dextromethorphan hydrobromide 30 mg and guaifenesin 600 mg prolonged-release oral tablet Has manufactured dose form Extended-release oral tablet true Inferred relationship Some
Dextromethorphan hydrobromide 30 mg and guaifenesin 600 mg prolonged-release oral tablet Has BoSS Guaifenesin true Inferred relationship Some 2
Dextromethorphan hydrobromide 30 mg and guaifenesin 600 mg prolonged-release oral tablet Has precise active ingredient Dextromethorphan hydrobromide true Inferred relationship Some 1
Dextromethorphan hydrobromide 30 mg and guaifenesin 600 mg prolonged-release oral tablet Has presentation strength numerator value 30 false Inferred relationship Some 1
Dextromethorphan hydrobromide 30 mg and guaifenesin 600 mg prolonged-release oral tablet Has precise active ingredient Guaifenesin true Inferred relationship Some 2
Dextromethorphan hydrobromide 30 mg and guaifenesin 600 mg prolonged-release oral tablet Has unit of presentation Tablet true Inferred relationship Some
Dextromethorphan hydrobromide 30 mg and guaifenesin 600 mg prolonged-release oral tablet Has presentation strength numerator unit mg true Inferred relationship Some 2
Dextromethorphan hydrobromide 30 mg and guaifenesin 600 mg prolonged-release oral tablet Count of base of active ingredient 2 false Inferred relationship Some
Dextromethorphan hydrobromide 30 mg and guaifenesin 600 mg prolonged-release oral tablet Is a Dextromethorphan and guaifenesin only product in oral dose form true Inferred relationship Some
Dextromethorphan hydrobromide 30 mg and guaifenesin 600 mg prolonged-release oral tablet Plays role Expectorant therapeutic role true Inferred relationship Some
Dextromethorphan hydrobromide 30 mg and guaifenesin 600 mg prolonged-release oral tablet Plays role Antitussive therapeutic role true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

Description inactivation indicator reference set

Back to Start